The Novel Coronavirus (SARS-Cov-2) Antigen Rapid Test device (saliva) is an in vitro diagnostic test for the qualitative detection of Novel Coronavirus antigens in human saliva, using the rapid immunochromatographicmethod. The identification is based on the monoclonal antibodies specific for the Novel Coronavirus antigen. It will provide information for clinician to prescribe correct medications.